ICLR

ICON and Cerner team up to streamline Late Phase Research Studies

[at noodls] – KANSAS CITY, Mo. and DUBLIN, Ireland – Jan. 8, 2013 – Cerner (Nasdaq: CERN), a global innovator in electronic health record (EHR) and research technology, and ICON plc, a global provider of outsourced … moreView todays social media effects on ICLRView the latest stocks trending across Twitter. Click to view dashboardSee who ICON is hiring next, click […]

ICON Central Laboratories Doubles Biospecimen Storage Capacity

[at noodls] – Dublin, Ireland, 12th November 2012 – ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, … moreView todays social media effects on ICLRView the latest stocks trending across Twitter. Click to view dashboard […]

ICON Launches New Functional Service Provision (FSP) Strategy

[at noodls] – FSP and resourcing services consolidated into a single division, DOCS Dublin, Ireland, 6 November, 2012 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services … moreView todays social media effects on ICLRView the latest stocks trending across Twitter. Click to view dashboard […]

ICON Reports Q3 revenue of $286 million, EPS of 29c and net new business of $450 million

[at noodls] – Highlights – Third Quarter Fiscal 2012 Net revenue of $286 million, a 19% increase year on year. Income from operations of $20.9 million or 7.3% of net revenue. EPS of 29 cents on net income of $17.7 million. … moreView todays social media effects on ICLRView the latest stocks trending across Twitter. Click to view dashboard […]

ICON Launches New Medical Imaging Solution for Early Phase Trials

[at noodls] – Streamlined early phase offering designed to support faster decision making Dublin, Ireland, 17 October, 2012 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development … moreView todays social media effects on ICLRView the latest stocks trending across Twitter. Click to view dashboard […]

ICON Partners with Korea National Enterprise for Clinical Trials

[at noodls] – Partnership aims to further advance clinical research in South Korea Dublin, Ireland, 3 October, 2012 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services … moreView todays social media effects on ICLRView the latest stocks trending across Twitter. Click to view dashboard […]